Rite Aid locations set to close in New Hampshire Three Rite Aid pharmacies were revealed to be closing soon. 72 Lafayette Road, North Hampton, New Hampshire 58 Calef Highway, Lee, New Hampshire ...

To improve outcomes for patients, new strategies are being explored, including dual-targeting CAR T-cell therapies, which have shown intrathecally delivered bivalent CAR T cells targeting EGFR and ...

While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June, MD, and his team at Penn—has revolutionized treatment for many blood cancers ...

In addition, huCART19-IL18 is manufactured in a rapid, 3-day process that is designed to preserve stem-cell–like characteristics and reduce exhaustion in T cells. 24,25 To mitigate ...

Key Takeaways MB-105, a CD5-targeted CAR-T cell therapy, is being evaluated in a phase 2 trial for relapsed or refractory CD5-positive T-cell lymphoma. The trial, led by Dr. Swaminathan P. Iyer, will ...

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

AbbVie engaged its third T cell cancer deal of 2025 Wednesday with a Xilio Therapeutics collaboration for tumor-activated immunotherapies worth up to $2.1 billion. The Chicago-based pharma dished out ...

Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped three new research collaborations focusing on autoimmune diseases. Candid ...

Gen-3 Turbo is able to create a ten-second video in a little over ten seconds. This only works image-to-video but offers quality on par with the slower Gen-3 Alpha model when using an image as the ...

But Dr. Palomba says the CAR T cell treatment worked well in patients who had already received many lines of therapy — up to 11 in some cases. In those patients, standard therapy didn’t work for long.